Author

Gurleen Kaur Tung

Observed names: G. Tung, GURLEEN K. TUNG, Gurleen K. Tung

Institutions: Guru Nanak Dev University, Case Western Reserve University

Observed institutions: Guru Nanak Dev University, University of Oklahoma Health Sciences Center, Case Western Reserve University

ORCID: 0000-0002-3526-9064

Observed ORCID: 0000-0002-3526-9064

OpenAlex ID: A5089359060

3D‐QSAR and scaffold hopping based designing of benzo[d]ox‐azol‐2(3H)‐one and 2‐oxazolo[4,5‐b]pyridin‐2(3H)‐one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation

2022 · Himanshu Verma, Gera Narendra, et al. · Archiv der Pharmazie · 13

Preparation and Characterisation of Liposomes of Bergenia Ciliata Extract and Evaluation of their Hepatoprotective Activity

2022 · Uzma Latief, Manjot Kaur, et al. · Journal of Pharmaceutical Sciences · 12

Genotoxic damage in end-stage renal disease

2018 · G. Gandhi, T. Mehta, et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 12

Sensitivity and specificity prediction of the buccal micronucleus cytome assay in end-stage renal disease patients on dialysis: A case-control study

2017 · G. Gandhi, G. Tung · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 12

Polygenic Risk Score Assessment for Coronary Artery Disease in Asian Indians

2024 · Madhusmita Rout, Gurleen Kaur Tung, et al. · Journal of Cardiovascular Translational Research · 10

Bergenia ciliata as a future candidate for liver diseases: a concise review

2022 · Uzma Latief, Gurleen Kaur Tung, et al. · The Journal of Basic and Applied Zoology · 10

Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach

2023 · Gera Narendra, Baddipadige Raju, et al. · International Journal of Biological Macromolecules · 9

Baseline and oxidatively damaged DNA in end-stage renal disease patients on varied hemodialysis regimens: a comet assay assessment

2023 · Gurleen Kaur Tung, Gursatej Gandhi · Molecular and Cellular Biochemistry · 7

Scaffold hopping based designing of selective ALDH1A1 inhibitors to overcome cyclophosphamide resistance: synthesis and biological evaluation

2023 · Gera Narendra, Baddipadige Raju, et al. · RSC Medicinal Chemistry · 5

In silico guided designing of optimized benzochalcones derivatives as potent CYP1B1 inhibitors: An integrated in vitro and ONIOM study

2022 · Himani Sharma, Baddipadige Raju, et al. · Journal of Molecular Graphics and Modelling · 5

Micro RNAs as Emerging Therapeutic Targets in Liver Diseases

2022 · Subheet Kumar Jain, Uzma Latief, et al. · Current Protein and Peptide Science · 5

Prognostic Markers in CKD Patients Stratified by Co-morbid Conditions and on Dialysis Therapy

2026 · Gursatej Gandhi, Gurleen Kaur Tung · SN Comprehensive Clinical Medicine

Abstract 6947: CRISPR/Cas9 kinome screen identifies PNKP as a novel fitness gene in HPV-negative head and neck squamous cell carcinoma

2025 · Gurleen Kaur Tung, Kate Chatfield-Reed, et al. · Cancer Research

1477-P: Improved Diabetes Risk Prediction Using Ancestry-Specific Polygenic Score—Results from the Asian Indian Diabetic Heart Study/Sikh Diabetes Study

2023 · GURLEEN K. TUNG, MADHUSMITA ROUT, et al. · Diabetes

Genomic Instability in a Case With Chronic Obstructive Uropathy and End-stage Renal Failure

2017 · Gurleen Kaur Tung, Gursatej Gandhi · Journal of Case Reports in Medical Science

DNA damage in a patient with Systemic Lupus Erythematosus and Nephropathy- A Case Report

2015 · Gurleen Kaur Tung, Gursatej Gandhi · International Journal of Biomedical Research

Works count: 16

Citation count: 100

H-index: 7

I10-index: 6